File Download
  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukaemia

TitleOral arsenic trioxide in the treatment of relapsed acute promyelocytic leukaemia
Authors
KeywordsMedical sciences
Issue Date2003
PublisherHong Kong Medical Association. The Journal's web site is located at http://www.hkmj.org.hk
Citation
The 8th Medical Research Conference (MRC 2003), Hong Kong, China, 25-26 January 2003. In Hong Kong Medical Journal, 2003, v. 9 supp 1, p. 59, abstract HO-06 How to Cite?
AbstractINTRODUTION: Arsenic trioxide (As2O3) induces a remission in over 90% of patients with relapsed acute promyelocytic leukaemia (APL). To date, only the intravenous (i.v.) preparation of As2O3 has been used. We have recently developed an oral preparation of As2O3 that achieves blood levels of elemental arsenic comparable with those of i.v. As2O3 (Eur J Clin Pharmacol Oct 11, 2002 online). In this study, the efficacy and safety of oral As2O3 were …
Persistent Identifierhttp://hdl.handle.net/10722/46908
ISSN
2015 Impact Factor: 0.887
2015 SCImago Journal Rankings: 0.279

 

DC FieldValueLanguage
dc.contributor.authorAu, WYen_HK
dc.contributor.authorKumana, CRen_HK
dc.contributor.authorKou, Men_HK
dc.contributor.authorMak, Ren_HK
dc.contributor.authorChan, GCFen_HK
dc.contributor.authorLam, CWen_HK
dc.contributor.authorKwong, YLen_HK
dc.date.accessioned2007-10-30T07:01:02Z-
dc.date.available2007-10-30T07:01:02Z-
dc.date.issued2003en_HK
dc.identifier.citationThe 8th Medical Research Conference (MRC 2003), Hong Kong, China, 25-26 January 2003. In Hong Kong Medical Journal, 2003, v. 9 supp 1, p. 59, abstract HO-06en_HK
dc.identifier.issn1024-2708en_HK
dc.identifier.urihttp://hdl.handle.net/10722/46908-
dc.description.abstractINTRODUTION: Arsenic trioxide (As2O3) induces a remission in over 90% of patients with relapsed acute promyelocytic leukaemia (APL). To date, only the intravenous (i.v.) preparation of As2O3 has been used. We have recently developed an oral preparation of As2O3 that achieves blood levels of elemental arsenic comparable with those of i.v. As2O3 (Eur J Clin Pharmacol Oct 11, 2002 online). In this study, the efficacy and safety of oral As2O3 were …-
dc.languageengen_HK
dc.publisherHong Kong Medical Association. The Journal's web site is located at http://www.hkmj.org.hken_HK
dc.relation.ispartofHong Kong Medical Journal-
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License-
dc.subjectMedical sciencesen_HK
dc.titleOral arsenic trioxide in the treatment of relapsed acute promyelocytic leukaemiaen_HK
dc.typeConference_Paperen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1024-2708&volume=9&issue=1 Supp 1&spage=24&epage=&date=2003&atitle=Oral+arsenic+trioxide+in+the+treatment+of+relapsed+acute+promyelocytic+leukaemiaen_HK
dc.description.naturepublished_or_final_versionen_HK
dc.identifier.hkuros82848-
dc.identifier.volume9-
dc.identifier.issuesupp 1-
dc.identifier.spage59, abstract HO-06-
dc.identifier.epage59, abstract HO-06-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats